Challenges of In Vitro Glycation when Producing Blood Materials for Hemoglobin A1C Immunoassays
Clinical Laboratory · 2023
DOI: 10.7754/clin.lab.2022.220619 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Laboratory, 2023. Verfasst von W Duanginta und 6 weiteren Autor:innen. Hauptthemen laut MEDLINE: Blood Glucose, Maillard Reaction. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
BACKGROUND: Blood materials are essential for quality control and assurance of hemoglobin A1C (HbA1C) measurements. This study presents an optimal condition for in vitro glycation to prepare blood materials for HbA1C with desired high HbA1C content and commutable with two immunoassays. METHODS: Washed erythrocytes were adjusted to a hematocrit (Hct) of 50 - 55% and glycated in vitro at 37°C for up to 120 hours with various concentrations of D-glucose in phosphate buffer saline to prepare blood materials for HbA1C. After glycation in each condition, glycation of blood material was inhibited and HbA1C level was monitored. The HbA1c in blood materials from in vitro glycation was compared in terms of stability and commutability with blood materials from other preparation methods. RESULTS: Incubation of erythrocytes with 400 mM D-glucose for 15 hours at 37°C resulted in a significant increase (p < 0.001) of HbA1c in blood materials by at least 40% with a remaining Hct between 38% to 42%. Hemoglobin A1C in blood materials was stable at 3.8 ± 0.8°C for 70 days and during transport for 3 days (temperature ranges from 8.1 to 23.5°C), after inhibition by glucose concentration solution. Hemoglobin A1C values in blood materials from in vitro glycation were commutable between enzymatic and turbidimetric immunoassay. CONCLUSIONS: An optimal condition for in vitro glycation by incubation of erythrocytes with 400 mM D-glucose for 15 hours at 37 °C was able to generate HbA1C material with intact erythrocytes that is sufficiently stable and commutable between enzymatic and turbidimetric immunoassay. Therefore, this condition is suitable for the preparation of blood material for HbA1C immunoassays.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Duanginta, W., Apiratmateekul, N., Kost, G. J., Tran, N. K., Kongros, K., Shearman, K., & Treebuphachatsakul, W. (2023). Challenges of In Vitro Glycation when Producing Blood Materials for Hemoglobin A1C Immunoassays. Clinical Laboratory. https://doi.org/10.7754/clin.lab.2022.220619
Vancouver
Duanginta W, Apiratmateekul N, Kost GJ, Tran NK, Kongros K, Shearman K, et al. Challenges of In Vitro Glycation when Producing Blood Materials for Hemoglobin A1C Immunoassays. Clinical Laboratory. 2023. doi:10.7754/clin.lab.2022.220619
BibTeX
@article{Duanginta2023,
author = {Duanginta, W and Apiratmateekul, N and Kost, G J and Tran, N K and Kongros, K and Shearman, K and Treebuphachatsakul, W},
title = {Challenges of In Vitro Glycation when Producing Blood Materials for Hemoglobin A1C Immunoassays},
journal = {Clinical Laboratory},
year = {2023},
doi = {10.7754/clin.lab.2022.220619}
}
EUVIMED